Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Jun 2019 07:00 AM
RNS
OXB and Santen enter R&D collaboration
25 Jun 2019 07:00 AM
RNS
Board Change
18 Jun 2019 07:15 AM
EQS
Oxford BioMedica (OXB): De-leveraging the balan...
10 Jun 2019 02:34 PM
RNS
Director/PDMR Shareholding
06 Jun 2019 01:08 PM
RNS
Axovant update on 1st cohort of Sunrise-PD trial
06 Jun 2019 11:39 AM
RNS
Holding(s) in Company
05 Jun 2019 12:06 PM
RNS
Holdings in Company
04 Jun 2019 05:38 PM
RNS
Holdings in Company
04 Jun 2019 09:59 AM
RNS
Total Voting Rights
03 Jun 2019 06:06 PM
RNS
Holding(s) in Company
03 Jun 2019 10:31 AM
RNS
Total Voting Rights
29 May 2019 06:19 PM
RNS
Exercise of Subscription Option by Novo Holdings
29 May 2019 01:06 PM
RNS
Result of AGM
28 May 2019 07:00 AM
RNS
Strategic Investment by Novo Holdings A/S
23 May 2019 06:04 PM
RNS
Director Dealings / Market Share Purchase
02 May 2019 02:53 PM
RNS
Long Term Incentive Plan Option Grant
01 May 2019 12:52 PM
RNS
REPLACEMENT: Total Voting Rights
01 May 2019 11:33 AM
RNS
Total Voting Rights
30 Apr 2019 05:38 PM
RNS
Holdings in Company
30 Apr 2019 01:35 PM
RNS
Oxford Biomedica to present at the ASGCT
30 Apr 2019 01:15 PM
RNS
Axovant doses second cohort of AXO-Lenti-PD
25 Apr 2019 03:38 PM
RNS
Director Dealings / Market Share Purchase
23 Apr 2019 01:47 PM
RNS
Deferred Bonus Plan and LTIP Option Grants
23 Apr 2019 11:38 AM
RNS
Director Dealings / Market Share Transactions
18 Apr 2019 05:33 PM
RNS
Exercise of warrants
18 Apr 2019 07:00 AM
RNS
Annual Report and Accounts & AGM Notification
02 Apr 2019 07:15 AM
EQS
Oxford BioMedica (OXB): Deal-making drives firs...
01 Apr 2019 11:40 AM
RNS
Total Voting Rights
26 Mar 2019 12:57 PM
RNS
Director Dealings / Market Share Purchase
26 Mar 2019 08:25 AM
RNS
Japanese approval of Kymriah® (tisagenlecleucel)
14 Mar 2019 07:00 AM
RNS
Preliminary Results
12 Mar 2019 07:00 AM
RNS
OXB announces R&D collaboration with Microsoft
11 Mar 2019 10:38 AM
RNS
Axovant's update on Phase 2 trial of AXO-Lenti-PD
01 Mar 2019 09:30 AM
RNS
Total Voting Rights
25 Feb 2019 12:23 PM
RNS
Director Dealings / Market Share Purchase
08 Feb 2019 07:00 AM
RNS
Notice of Results
07 Feb 2019 11:49 AM
RNS
Director/PDMR Shareholding
07 Feb 2019 09:22 AM
RNS
Update on programmes outlicensed to Sanofi
06 Feb 2019 11:00 AM
RNS
Director Dealings / Market Share Transactions
05 Feb 2019 10:22 AM
RNS
Director Dealings / Market Share Purchase
01 Feb 2019 10:00 AM
RNS
Total Voting Rights
24 Jan 2019 11:20 AM
RNS
Director Dealings / Market Share Purchase
18 Jan 2019 10:51 AM
RNS
Director Dealings / Market Share Purchase
03 Jan 2019 12:20 PM
RNS
Block listing Interim Review
02 Jan 2019 10:17 AM
RNS
Total Voting Rights
21 Dec 2018 01:16 PM
RNS
Director Dealings / Market Share Purchase
06 Dec 2018 04:11 PM
RNS
Axovant FDA meeting feedback
03 Dec 2018 09:53 AM
RNS
Total Voting Rights
03 Dec 2018 07:00 AM
RNS
Longer term Kymriah efficacy and safety data
23 Nov 2018 10:41 AM
RNS
Director Dealings
UK 100

Latest directors dealings